Serotonin News and Research

Latest Serotonin News and Research

Complementary medicine risks: an interview with Dr Andrew Boyden, NPS MedicineWise

Complementary medicines include products containing herbs, vitamins, minerals, nutritional supplements, homoeopathic medicines, certain aromatherapy products and traditional Chinese medicines. For this reason they are also called herbal, natural or alternative medicines.

26 Feb 2013

Research on animal models demonstrates that antidepressants are not a cure as such

We should reconsider how we use antidepressants more effectively. The latest studies have shown that antidepressants restore the capacity of certain areas of the brain to repair abnormal neural pathways. According to neuroscientist Eero Castrén, the recipient of EUR 2.5 million of ERC funding, recovery requires redirection of these pathways through practice, rehabilitation or therapy.

22 Feb 2013

Physiotherapy aids defecation in constipated children

Physiotherapy may be an effective complementary therapy to laxatives for treating constipation in children, research indicates.

20 Feb 2013

Study finds chemical cues that allow seals’ brain to remain half awake and asleep

A new study led by an international team of biologists has identified some of the brain chemicals that allow seals to sleep with half of their brain at a time.

20 Feb 2013

Patients with untreated depression are poorly protected by shingles vaccination

Results from a new study published in Clinical Infectious Diseases suggest a link between untreated depression in older adults and decreased effectiveness of the herpes zoster, or shingles, vaccine.

16 Feb 2013

Depression reduces efficacy of shingles vaccine

Research suggests that the varicella zoster, or shingles, vaccine is less effective in older people with untreated depression.

15 Feb 2013

Researchers identify new way to influence the vital serotonin signaling system

An interdisciplinary team of researchers from the University of Texas Medical Branch at Galveston and the University of Houston has found a new way to influence the vital serotonin signaling system - possibly leading to more effective medications with fewer side effects.

14 Feb 2013

Threat vigilance can protect soldiers against PTSD

The onset of Post-Traumatic Stress Disorder (PTSD) is unpredictable. Because it depends on the unforeseeable occurrence of traumatic events, it is difficult to identify preventative or causative factors. Scientists typically turn to patients who have already developed PTSD to study the disorder, but that means they can't draw comparisons to their psychological state prior to experiencing trauma.

14 Feb 2013

CELF6 genetic mutation may underlie common behaviors seen in people with autism

Scientists at Washington University School of Medicine in St. Louis have identified a genetic mutation that may underlie common behaviors seen in some people with autism, such as difficulty communicating and resistance to change.

14 Feb 2013

Northwestern Medicine expert offers tips to battle seasonal affective disorder

Winter is in full force. With short days and less exposure to sunlight, everyone feels less energetic and more people are vulnerable to depression. Seasonal Affective Disorder (SAD), or winter depression, is a mood disorder related to seasonal variations of light. Symptoms start in late fall and oftentimes last until April or early spring. It affects between 10 to 20 percent of Americans, primarily younger adults and women.

10 Feb 2013

Broken motors induce stress and anxiety in mice

When motors break down, getting where you want to go becomes a struggle. Problems arise in much the same way for critical brain receptors when the molecular motors they depend on fail to operate. Now, researchers reporting in Cell Reports, a Cell Press publication, on February 7, have shown these broken motors induce stress and anxiety in mice. The discovery may point the way to new kinds of drugs to treat anxiety and other disorders.

10 Feb 2013

Book reviews psilocybin's potential in alleviating psychological distress in cancer patients

Improvements in the diagnosis and treatment of cancers in recent years have led to a marked increase in patients' physical survival rates. While doctors can treat the physical disease, what is not well understood is how best to address the psychological needs of patients with cancer.

1 Feb 2013

STA announces results from ABRAXANE plus gemcitabine phase III trial on pancreatic cancer

Australian biopharmaceutical company Specialised Therapeutics Australia announces that a phase III clinical trial of world leading breast cancer drug ABRAXANE (nanoparticle albumin-bound paclitaxel) in combination with current standard of care gemcitabine in patients with advanced pancreatic cancer has demonstrated substantially improved survival times, with double the number of patients surviving two years.

23 Jan 2013

Itch-specific nerve cells: an interview with Associate Professor Xinzhong Dong

Itch was actually defined by a German physician more than 350 years ago. His name was Samuel Hafenreffer. He defined itch as an unpleasant sensation that makes people want to scratch. You probably think this is a very simple definition but itch is really a very complex sensory modality.

21 Jan 2013

TMD pain might reflect physical manifestation of anxiety or depression

There is an ongoing debate about the role of psychological disorder symptoms as risk factors for temporomandibular joint (TMJ) pain. Previous studies have associated depression and TMJ pain but large scale studies have not been performed.

17 Jan 2013

Fifteen established scientists to receive NARSAD Distinguished Investigator Grants

The Brain & Behavior Research Foundation (formerly NARSAD, the National Alliance for Research on Schizophrenia and Depression) announced the latest recipients of its highly competitive NARSAD Distinguished Investigator Grants.

16 Jan 2013

Reviva Pharmaceuticals completes enrollment in RP5063 phase 2 trial for schizophrenia

Reviva Pharmaceuticals, Inc., a privately held drug discovery and development company, today announces completion of patient enrollment in the phase 2 clinical trial of RP5063 for the treatment of schizophrenia and schizoaffective disorder.

16 Jan 2013

Fluoxetine stimulates production of new neurons from L1-INP cells

The production of new neurons in the adult normal cortex in response to the antidepressant, fluoxetine, is reported in a study published online this week in Neuropsychopharmacology.

7 Jan 2013

Link between SSRI use in pregnancy and stillbirth refuted

Study findings suggest that use of selective serotonin reuptake inhibitors during pregnancy does not pose any increased infant mortality risk.

3 Jan 2013

No significant link between SSRI use during pregnancy and risk of stillbirth, neonatal death

In a study that included nearly 30,000 women from Nordic countries who had filled a selective serotonin reuptake inhibitor (SSRI) prescription during pregnancy, researchers found no significant association between use of these medications during pregnancy and risk of stillbirth, neonatal death, or postneonatal death, after accounting for factors including maternal psychiatric disease, according to a study in the January 2 issue of JAMA.

1 Jan 2013

Serotonin News and Research

Latest Serotonin News and Research

Complementary medicine risks: an interview with Dr Andrew Boyden, NPS MedicineWise

Research on animal models demonstrates that antidepressants are not a cure as such

Physiotherapy aids defecation in constipated children

Study finds chemical cues that allow seals’ brain to remain half awake and asleep

Patients with untreated depression are poorly protected by shingles vaccination

Depression reduces efficacy of shingles vaccine

Researchers identify new way to influence the vital serotonin signaling system

Threat vigilance can protect soldiers against PTSD

CELF6 genetic mutation may underlie common behaviors seen in people with autism

Northwestern Medicine expert offers tips to battle seasonal affective disorder

Broken motors induce stress and anxiety in mice

Book reviews psilocybin's potential in alleviating psychological distress in cancer patients

STA announces results from ABRAXANE plus gemcitabine phase III trial on pancreatic cancer

Itch-specific nerve cells: an interview with Associate Professor Xinzhong Dong

TMD pain might reflect physical manifestation of anxiety or depression

Fifteen established scientists to receive NARSAD Distinguished Investigator Grants

Reviva Pharmaceuticals completes enrollment in RP5063 phase 2 trial for schizophrenia

Fluoxetine stimulates production of new neurons from L1-INP cells

Link between SSRI use in pregnancy and stillbirth refuted

No significant link between SSRI use during pregnancy and risk of stillbirth, neonatal death

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Serotonin News and Research

Latest Serotonin News and Research

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Newsletters you may be interested in